Navigation Links
Mirixa Corporation Announces MirixaEdge(SM)
Date:10/19/2009

NEW ORLEANS, Oct. 19 /PRNewswire/ -- NCPA 111th Annual Convention -- Mirixa Corporation, the leader in targeted pharmacy-based patient care services, has announced the launch of MirixaEdge(SM). Previewed to independent pharmacists at the National Community Pharmacists Association's annual convention, MirixaEdge enables pharmacists to design their own patient care programs for any of their patients regardless of health plan, employer, or age.

MirixaEdge capitalizes on the nation's leading web-based clinical platform, MirixaPro(SM), which is available to over 40,000 contracted pharmacies nationwide to identify patient health care issues, highlight potential medication-related interactions, and encourage standardized care by pharmacists. MirixaEdge helps jumpstart the process of personalized program creation by providing pharmacists with pre-defined templates for conditions such as diabetes, asthma, and cardiovascular disease. Pharmacists can also take advantage of a template for medication therapy management. Additional MirixaEdge templates are planned.

"MirixaEdge helps pharmacists improve health outcomes for their patients, drive down health care costs and provide greater access to care," said Rick Solano, Mirixa's Chief Executive Officer. "The product expands patient care opportunities for community pharmacy and enables pharmacists to proactively engage their patients in the kind of dialogue that drives customer loyalty and trust."

MirixaEdge provides pharmacies with a standardized platform on which to establish their unique pharmacy patient care programs, capture outcomes measurements, and use that information to educate patients about their health issues.

A select group of MirixaPro participating pharmacies have participated in beta testing of MirixaEdge. One member of the pilot group, Justin Wilson, PharmD., of Valu-Med Pharmacy in Midwest City, OK, anticipates that using MirixaEdge will enhance customer relations and notes, "This tool will provide our pharmacy with a mechanism to proactively engage patients in a dialogue about their medication. By initiating a discussion, our pharmacists will be better able to advise and educate the patient while at the same time encouraging them to adhere to their medication regime and to focus on healthy lifestyle choices."

About Mirixa

Mirixa Corporation, sponsored by the National Community Pharmacists Association (NCPA), is the leader in targeted patient care services delivered via the nation's largest pharmacy-based patient care network. Dedicated to improving patients' health, Mirixa enables the health care community to deliver patient care services through retail pharmacy. The MirixaPro(SM) web-based clinical platform is used by pharmacists to deliver standardized patient care services. For more information, please visit www.Mirixa.com.

    Contact:     Anne Marie Heil
                 610-933-8065 (o)
                 484-886-7540 (c)
                 amheil@amheil.com

SOURCE Mirixa Corporation


'/>"/>
SOURCE Mirixa Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Mirixa Corporation Announces Key Pharmacy Network Hire
2. WebMD and HLTH Corporation to Webcast Annual Meetings of Stockholders
3. Baxa Corporation Signs Exclusive Distribution Agreement With Leading Pharmaceutical Corporation in Peoples Republic of China
4. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
5. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference
6. CEL-SCI Corporation Releases Letter to Shareholders
7. ETEX Corporation Announces Additional FDA Clearance For EquivaBone(R), The First Hard Setting Osteoconductive and Osteoinductive Bone Graft Substitute.
8. Clinical Logistics Enters Partnership with Gentris Corporation
9. Exsulin Corporation Announces Next Phase II Trial of Novel Islet Regeneration Treatment in Type 1 Diabetes
10. Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer
11. Celladon Corporation Announces Presentation of First-in-Human Gene Transfer to Treat Heart Failure at the 12th Annual Meeting of the American Society of Gene Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  AcelRx Pharmaceuticals, ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that Vincent J. Angotti ... a member of the company,s board of directors, ... over two decades of experience leading executive and ...
(Date:2/16/2017)... -- Prescription pain medications provided by "physicians in the months ... opioid use to take hold," according to a new ... The New England Journal of Medicine (NEJM). ... acute pain than in almost any other medical setting," ... the American College of Emergency Physicians. "The challenge is ...
(Date:2/16/2017)... Research and Markets has announced the addition of the "Global ... Cancer Type, Technology - Forecast to 2025" report to their ... The ... a CAGR of around 28.6% over the next decade to reach ... the prominent trends that the market is witnessing include increasing demand ...
Breaking Medicine Technology:
(Date:2/18/2017)... (PRWEB) , ... February 18, 2017 , ... ... today provides the latest information and contact points to easily connect elderly veterans ... care, assisted living, and elder-care funding. It also conveys material on this year's ...
(Date:2/17/2017)... Nashville, TN (PRWEB) , ... February 17, 2017 ... ... Services, Inc. (ISTS) brings its educational assistance management solution to the exhibit floor ... Convention Center in Orlando, Fla. , From Feb. 19–23, 2017, more than ...
(Date:2/17/2017)... ... February 17, 2017 , ... Access today announced that ... Orlando, Fla., February 19-23. Visitors to the company’s booth (#1778) will be the ... patient signatures solution in healthcare . , Since it first introduced Electronic ...
(Date:2/17/2017)... ... February 17, 2017 , ... Cancer diagnostics workflow ... Tri-Conference February 20 – 22 in San Francisco. As part of the Tri-Conference ... molecular pathology workflow solution, as well as its new precision medicine platform, “Crosswalk ...
(Date:2/16/2017)... New York, New York (PRWEB) , ... February ... ... hard work and determination. After what took over 10 years of research, development ... disruptive technology, NTX Technology™. NTX Technology™ is a patented compound of FDA approved ...
Breaking Medicine News(10 mins):